VASCULITIDES AS MEDICATION-INDUCED ADVERSE EVENTS BASED ON A NATIONAL DATABASE REPORTING SYSTEM

被引：0
|
作者：
Rodriguez-Pla, A. [1 ]
机构：
[1] Mayo Clin, Rheumatol, Scottsdale, AZ USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2022年 / 81卷
关键词：
D O I：
10.1136/annrheumdis-2022-eular.2207
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
POS0827
引用
收藏
页码：704 / 704
页数：1
相关论文
共 50 条
  • [1] Vasculitides as Medication-Associated Adverse Events Based on a National Database Reporting System
    Rodriguez-Pla, Alicia
    [J]. ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 3112 - 3113
  • [2] MEDICATION-INDUCED TAKOTSUBO SYNDROME: INSIGHTS FROM FDA ADVERSE EVENT REPORTING SYSTEM DATABASE
    Niu, Haiming
    Yuan, Yong, Sr.
    Li, Jianwei, Sr.
    Shi, Ao
    Cai, Peng
    Chen, Miaolian
    Peddibhotla, Bharath
    Liang, Hongkai
    Feng, Li, Sr.
    Li, Mingxing, Sr.
    Teng, Catherine
    Li, Pengyang
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 740 - 740
  • [3] Basic and Clinical Research Based on Clinical Questions: Reduction of Antipsychotic Medication-induced Adverse Events
    Ishikawa, Shuhei
    [J]. YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2023, 143 (10): : 777 - 783
  • [4] 'Extreme duplication' in the USFDA adverse events reporting system database
    Reich, Lester
    [J]. DRUG SAFETY, 2007, 30 (06) : 551 - 554
  • [5] Medication-induced osteonecrosis of the jaw: a review of cases from the Food and Drug Administration Adverse Event Reporting System (FAERS)
    Ahdi, Hardeep S.
    Wichelmann, Thomas Adam
    Pandravada, Sasirekha
    Ehrenpreis, Eli D.
    [J]. BMC PHARMACOLOGY & TOXICOLOGY, 2023, 24 (01):
  • [6] Medication-induced osteonecrosis of the jaw: a review of cases from the Food and Drug Administration Adverse Event Reporting System (FAERS)
    Hardeep S. Ahdi
    Thomas Adam Wichelmann
    Sasirekha Pandravada
    Eli D. Ehrenpreis
    [J]. BMC Pharmacology and Toxicology, 24
  • [7] Gender differences in the adverse events induced by cardiovascular drugs: Using National Adverse Event Reporting and health insurance database
    Park, Han-Heui
    Yoon, Dongwon
    Kim, Ju Hwan
    Shin, Ju-Young
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 560 - 560
  • [8] Pharmacovigilance analysis of orlistat adverse events based on the FDA adverse event reporting system (FAERS) database
    Zhu, Jinfeng
    Hu, Mianda
    Liang, Yingshi
    Zhong, Mingjun
    Chen, Zilin
    Wang, Zhenjie
    Yang, Yujia
    Luo, Ziyi
    Zeng, Wenqi
    Li, Jiahui
    Du, Yikuan
    Liu, Yi
    Yang, Chun
    [J]. HELIYON, 2024, 10 (14)
  • [9] ‘Extreme Duplication’ in the US FDA Adverse Events Reporting System Database
    Manfred Hauben
    Lester Reich
    James De Micco
    Katherine Kim
    [J]. Drug Safety, 2007, 30 : 551 - 554
  • [10] Serious adverse events associated with hormonal contraceptive use for acne treatment, based on reporting to the FDA Adverse Events Reporting Database
    Rao, Elizabeth M.
    Carroll, Bryan T.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB108 - AB108
12345